Tue, November 15, 2022

Sean Lee Maintained (CASI) at Strong Buy with Decreased Target to $10 on, Nov 15th, 2022

Sean Lee of HC Wainwright & Co., Maintained "CASI Pharmaceuticals, Inc." (CASI) at Strong Buy with Decreased Target from $12 to $10 on, Nov 15th, 2022.

Sean has made no other calls on CASI in the last 4 months.



There is 1 other peer that has a rating on CASI. Out of the 1 peers that are also analyzing CASI, 0 agree with Sean's Rating of Hold.



This is the rating of the analyst that currently disagrees with Sean


  • Swayampakula Ramakanth of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $12 on, Monday, August 15th, 2022